The Peregrine Fund, Inc.

Audits
4
Findings
28
Total Expended
$7.24M
Latest Accepted
2026-02-25
Location: Boise, ID
UEI: JQNWNLUK2KL3 EIN: 231969973

SAM.gov Exclusion Status:

Checking exclusion status...
Loading recommendations...

Contacts

Name Title Type
Craig Lochner Chief Financial Officer Auditee
Andreas Alexandrou Director Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
389127 2025 2026-02-25 GELMAN ROSENBERG & FREEDMAN $2.10M
346612 2024 2025-03-18 Gelman Rosenberg & Freedman $2.04M
297405 2023 2024-03-25 Gelman Rosenberg & Freedman $1.68M
42944 2022 2023-03-28 Gelman Rosenberg & Freedman $1.42M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
389127 2025 2026-02-25 1175413 2025-001 Material Weakness Yes M
389127 2025 2026-02-25 1175412 2025-001 Material Weakness Yes M
346612 2024 2025-03-18 1105090 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 1105089 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 1105088 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 1105087 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 1105086 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 1105085 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 1105084 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 528648 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 528647 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 528646 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 528645 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 528644 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 528643 2024-003 Significant Deficiency Yes I
346612 2024 2025-03-18 528642 2024-003 Significant Deficiency Yes I
297405 2023 2024-03-25 960722 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 960721 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 960720 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 960719 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 960718 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 960717 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 384280 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 384279 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 384278 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 384277 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 384276 2023-003 Significant Deficiency - I
297405 2023 2024-03-25 384275 2023-003 Significant Deficiency - I